Salix
Pharmaceuticals Ltd. (Nasdaq: SLXP) fell to a loss for the third quarter of $1.39 per diluted share compared with earnings of 71 cents per diluted share in the year ago period and
announced the resignation of chief financial officer Adam C. Derbyshire.
Salix falls to loss, CFO resigns
November 07, 2014 at 04:30 AM EST
